Karin Juliette Van Charldorp,Brigitte Johanna Fanny Bosman,Monique Maria Alida Klaver,Alberto Garcia Hernandez,Tennis Edwin Drogendijk
申请号：
US13909526
公开号：
US20130267557A1
申请日:
2013.06.04
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The combined use of (R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide (tamsulosin), or its pharmaceutically acceptable salt, and (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt, for the preparation of a medicament for the improvement of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) with a substantial storage component is provided.
